Are you looking for a potential new celiac disease treatment?
The LILY Study is a phase 1 celiac disease study that will measure the safety of the study medication, DONQ52, for targeting an immune complex known to cause celiac disease symptoms.
There is no gluten challenge in this study. You may be compensated for time and travel.
- You are 18-70 years old
- You have celiac disease
- You are already on a gluten-free diet for at least 12 months
- Have or can obtain medical records which show diagnosis of celiac disease
- Other requirements will apply.
Study Site Locations:
- Multisite (US)
If you’re interested in the study, think you may qualify, or want to find a study site location near you, visit www.celiacdiseasestudy.com